Accuracy of in vivo neuroreceptor quantification by PET and review of steady-state, transient, double injection, and equilibrium models.
暂无分享,去创建一个
B R Zeeberg | R E Gibson | R C Reba | B. Zeeberg | R. Reba | R. Gibson
[1] O. Inoue,et al. Visualization of specific binding sites of benzodiazepine in human brain. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[3] C. D. Arnett,et al. A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. , 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[4] C. Lawson,et al. Solving least squares problems , 1976, Classics in applied mathematics.
[5] B R Zeeberg,et al. Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction. , 1987, Bulletin of mathematical biology.
[6] R. Reba,et al. The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] Paul O. Scheibe,et al. Identifiability Analysis of an In Vivo Receptor-Binding Radiopharmacokinetic System , 1985, IEEE Transactions on Biomedical Engineering.
[8] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[9] Henry N. Wagner,et al. Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters , 1984, Brain Research.
[10] J M Links,et al. 3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] M E Phelps,et al. Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] K A Frey,et al. Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[13] C. Lanczos. Applied Analysis , 1961 .
[14] P. Seeman,et al. Dopamine receptors in brain and periphery , 1987, Neurochemistry International.
[15] D Comar,et al. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.
[16] J M Links,et al. Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] B. Zeeberg,et al. Quantification of Human Caudate D2 Dopamine Receptor Density with Positron Emission Tomography: A Review of the Model , 1987, IEEE Transactions on Medical Imaging.
[18] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[19] Michael V. Green,et al. Theoretical Analysis of Optimal Conditions in Fquilibrium Imaging of in Vivo Receptors , 1985, IEEE Transactions on Nuclear Science.
[20] J. Barrio,et al. Nonlinearity in Modeling Receptor-Binding Ligands , 1987 .
[21] J B Bassingthwaighte,et al. Sensitivity functions in the estimation of parameters of cellular exchange. , 1984, Federation proceedings.
[22] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[23] C. D. Arnett,et al. Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.
[24] K. B. Larson,et al. Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] B. Zeeberg,et al. Elevated D2 dopamine receptors in drug-naïve schizophrenics. , 1988, Science.
[26] M. Raichle,et al. Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors , 1980, Brain Research.
[27] J S Fowler,et al. Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers , 1987, Journal of neurochemistry.
[28] J. Fields,et al. 3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain. , 1978, European journal of pharmacology.
[29] A. Gjedde,et al. Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[31] G T Gullberg,et al. Quantitative potentials of dynamic emission computed tomography. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.